Avantra Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,382
Closed -$344K 160
2025
Q4
$344K Sell
6,382
-66
-1% -$3.17K 0.25% 114
2025
Q3
$291K Buy
+6,448
New +$301K 0.22% 126

Other funds holding BMY

Avantra Family Wealth's BMY Position: Q1 2026 in Review

Avantra Family Wealth sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 6,382 shares — an estimated $344K sold.

Avantra Family Wealth first reported a position in BMY in Q3 2025 and held it in 2 quarters. The position peaked at $344K in Q4 2025. 2,527 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Avantra Family Wealth reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Avantra Family Wealth sold 6,382 Bristol-Myers Squibb shares in Q1 2026, an estimated $344K.
  • Avantra Family Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and held it in 2 quarters.
  • Avantra Family Wealth's Bristol-Myers Squibb position peaked at $344K in Q4 2025.
  • 2,527 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Avantra Family Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.